When it comes to improving how we detect, manage, and prevent a medical condition, discovering new options is only the beginning. Before it can be made available to the public, each must be thoroughly tested on humans in studies called clinical trials. The diversity in the volunteers who participate plays a vital role in clinical research we can’t afford to do without.

Diversity is More than Race

Diversity means more than a racial or ethnic background. While this is part of it, age, gender, demographics, and lifestyles are others. Why are these things important? Because potentially new drugs, devices, and therapeutic approaches should be studied in the population of people they are meant to help. For example, being over 45 and in specific ethnic groups are some of the factors that increase your risk of developing diabetes.

We could relate these to traditional cuisines or another related cultural custom. We have some answers, but there is still more to learn before an exact cause is found. Diversity makes treatments safer and more effective for everyone.

Diversity’s Role in COVID-19 Vaccine Studies

There are many different types of research studies. Vaccines come to mind as we continue the fight against COVID-19 and marvel as the first vaccines doses are administered. It won’t be available to everyone at first, though. Healthcare workers, older adults (65 and up) and those at higher risk of developing more severe symptoms are among the first groups slated for vaccination. Pre-existing health conditions can put adults of any age at increased risk. Some examples are:

• Cancer
• Chronic kidney disease
• COPD (chronic obstructive pulmonary disease)
• Heart conditions, such as heart failure, coronary artery disease, or cardiomyopathies
• Immunocompromised state (weakened immune system) from solid organ transplant
• Sickle cell disease
• Smoking
• Type 2 diabetes mellitus
• Obesity

COVID-19 Vaccine Studies at ActivMed Practices & Research

There are over 400,000 registry participants in coronavirus related research studies. 19% represent ages 65-74, and 4% are over 75. In a virus where 80% of related deaths are age 65 and older, the numbers are concerning. Regardless of age, volunteering in clinical research allows you an opportunity to ensure the safest and most effective treatments for future generations.

To learn more about the COVID-19 vaccine studies currently enrolling here at ActivMed Practices & Research, contact our Portsmouth, NH location at (603) 319-8863, or visit our website.

References:

https://www.fda.gov/patients/clinical-trials-what-patients-need-know/diversity-clinical-trial-participation

https://www.pfizer.com/news/featured_stories/featured_stories_detail/diversity_in_clinical_trials_why_it_s_important

https://www.aarp.org/health/conditions-treatments/info-2020/range-of-subjects-in-vaccine-trials.html